2017 International Congress Archives - Page 53 of 155

Early caudate involvement in Parkinson’s disease may predict future cognitive decline

R. Durcan, D. Brooks, D. Burn, N. Pavese (Newcastle Upon Tyne, United Kingdom)
Early cognitive impairment phenotype and functional connectivity in non-demented Parkinson’s disease patients

K. Kawabata, H. Watanabe, K. Hara, E. Bagarinao, N. Yoneyama, A. Ogura, K. Imai, M. Masuda, T. Yokoi, R. Ohdake, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)
Early diagnosis in Spinocerebellar Ataxias: Prospects for clinical alterations and ethical dilemmas during preclinical trials.

L. Velázquez-Pérez, R. Rodríguez-Labrada, J. Rodríguez-Diaz, Y. Vazquez-Mojena, J. Medrano-Montero, A. Estupiñán-Rodríguez (Holguín, Cuba)
Early morning OFF problems are common in PD patients attending a routine clinical appointment

F. Stocchi, C. Coletti, S. Bonassi, L. Vacca (Rome, Italy)
Early-Onset Parkinson Disease with Hypocalcemia: Adult Presentation of 22q11.2 Deletion Syndrome

F. Moreira, J. Lopes, M. Sousa, L. Pires, C. Januário (Coimbra, Portugal)
Early-Onset Parkinsonism and Short Stature in a Puerto Rican Kindred. Possible DJ1 deletion?

K. Celis, J. Vance, A. Vinuela (Miami, FL, USA)
eEF1A2 promotes cell survival and protects against MPP+-induced apoptotic neuronal death through the PI3K/Akt/mTOR pathway

K. Khwanraj, P. Dharmasaroja, B. Morris (Ratchathewi, Thailand)
EEG Markers for Emotional Inhibition in Parkinson’s Disease

N. Dissanayaka, D. Hennessy, T. Au, A. Angwin, J.H. Yang, J. O'Sullivan, D. Copland (Brisbane, Australia)
EEG Shows Subclinical Motor Preparation Deficits in Parkinson’s Disease Patients with Freezing of Gait During Locomotion

C. Fearon, J. Butler, S. Waechter, I. Killane, L. Newman, T. Munteanu, D. Birsanu, B. Magennis, R. Reilly, T. Lynch (Dublin 7, Ireland)
Effect of bilateral subthalamic nucleus deep brain stimulation on quality of life in advanced Parkinson’s disease patients

s. tandra, B. ramavath, r.m. kandadai, r. borgohain (hyderabad, India)
Effect of deep brain stimulation of the subthalamic nucleus on cranial tremor in Parkinson’s disease

L. Cameron, C. Kilbane, A. Shaikh (Cleveland, OH, USA)
Effect of deep brain stimulation on visuospatial impairment in Parkinson’s disease

Y. Okahara, Y. Higuchi, K. Aoyagi, M. Abe, T. Yamamoto, Y. Yamanaka, S. Hirano, Y. Iwadate (Chiba, Japan)
Effect of Deutetrabenazine by Body Region Score of the Abnormal Involuntary Movement Scale in Tardive Dyskinesia: ARM-TD and AIM-TD Studies

H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, K. Anderson (Cleveland, OH, USA)
Effect of Deutetrabenazine on QTcF Interval in the AIM-TD Study: a 12-Week, Phase III, Randomized, Double-Blind, Placebo-Controlled Study

K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Washington, DC, USA)
Effect of Deutetrabenazine on Quality of Life in Patients With Tardive Dyskinesia in AIM-TD, a 12-Week Double-Blind, Placebo-Controlled Study

S. Factor, K. Anderson, D. Stamler, M. Davis, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Atlanta, GA, USA)
Effect of Droxidopa Treatment on Fear of Falling in Patients With Neurogenic Orthostatic Hypotension: Clinical Trial and “Real World” Results

S. Kymes, C. François, G. Peng, G. Rowse, S. Isaacson (Deerfield, IL, USA)
Effect of early AbobotulinumtoxinA (Dysport®) use after stroke on the time to reach reinjection criteria: asymptomatic versus symptomatic patients

R. Rosales, K.J. Goh, W. Kumthornthip, M. Mazlan, L. Abdul Latif, M.M. DeLos Santos, C. Chotiyarnwong, P. Tanvijit, J. Balcaitiene, P. Maisonobe, K.-H. Kong (Manila, Philippines)
Effect of food on Opicapone pharmacokinetics and pharmacodynamics

A. Santos, A. Falcão, J. Ferreira, A. Lees, B. Hernandez, F. Rocha, P. Soares-da-Silva (S. Mamede Coronado, Portugal)
Effect of levodopa-carbidopa intestinal gel on dyskinesia: Design of an open-label, randomized multicenter 12-week study in advanced Parkinson’s disease patients

A. Antonini, W. Poewe, D. Standaert, C. Zadikoff, S. Dubow, L. Bergmann, A. Yegin, C. Hall, W. Robieson, V. Felipe, L. Barbato (Venice, Italy)
Effect of low frequency stimulation on freezing of gait in a PSP patient with bilateral STN DBS

T. Xie, M. Padmanaban (Chicago, IL, USA)
Effect Of Non-Invasive Vagus Nerve Stimulation In Freezing And Oxidative Stress In Parkinson’s Disease Patients

B. MONDAL, S. CHOUDHURY, G. PAUL, M. MONDAL, M. BAKER, K. CHATTERJEE, P. CHATTERJEE, R. BANERJEE, R. SINGH, H. KUMAR (KOLKATA, India)
Effect of object size and obstacle avoidance on of Reach-to-Grasp Actions in Individuals with Parkinson’s disease

S. Khacharoen, J. Tretriluxana, P. Srivanitchapoom, A. Pisarnpong, T. Chandharohit (Nakhon Pathom, Thailand)
Effect of Personal Characteristics on Semiology of the First Tic Episode in Children with Tourette Syndrome

J. Oražem Mrak, J. Kodrič, D. Osredkar, D. Neubauer (Ljubljana, Slovenia)
Effect of Pridopidine on Total Functional Capacity (TFC) in Huntington Disease (HD): Results of a Cohort Comparison of Open-HART and Historical Placebo Subjects

A. McGarry, V. Abler, P. Auinger, I. Grachev, S. Gandhi, S. Papapetropoulos (Camden, NJ, USA)
Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)
Effect of Valproic Acid on Dystonia in a patient with Traumatic Brain Injury: a case report.

N. Fatima (Lahore, Pakistan)
Effect of Virtual Reality on Balance Rehabilitation

B. Zeigelboim, H. Teive, G. Dos Santos, M. Severiano (Curitiba, Brazil)
Effectiveness of Deep Brain Stimulation (DBS) in Mice with Spinocerebellar Ataxia (SCA1).

V. Vedam-Mai, K. McFarland, R. Nathu, S. Kurtovic, Q. Zhang, T. Ashizawa, M. Okun (Gainesville, FL, USA)
Effectiveness of lead position with MER to determine STNs: A study of MER with DBS for quantifying the effects of DBS in Parkinson`s disease

V. Rama Raju, R. Borgohain (HYDERABAD, India)
Effects of a Aquatic Dual Task Activity Program on the Quality of Life and Activities of Daily Living in Individuals with Parkinson’s Disease

A. Silva, V. Israel (Curitiba, Brazil)
Effects of a Parkinson-Specific, Interdisciplinary Approach, To Inpatient Rehabilitation

C. Benedict, D. Fredericks, C. Manganiello, H. Herrstrom, D. Schmitt, K. Lyons (Topeka, KS, USA)
Effects of bilateral pallidal deep brain stimulation for chorea after pulmonary thromboendarterectomy with deep hypothermia and circulatory arrest: case report

K. Aoyagi, Y. Higuchi, Y. Okahara, Y. Yamanaka, T. Yamamoto, S. Hirano, Y. Iwadate (Ichihara, Japan)
Effects of continuous apomorphine infusion on motor and nonmotor symptoms in Parkinson’s disease without cognitive deterioration

J.-F. Houvenaghel, S. Drapier, J. Duprez, D. Drapier, M. Vérin (Rennes, France)
Effects of deep brain stimulation in genetic parkinsonism

L. Oliveira, R. Cury, E. Barbosa (Sao Paulo, Brazil)
Effects of deep brain stimulation on olfactory function in Parkinson’s disease

R. Cury, M. Carvalho, M.g. Santos Ghilardi, A. Estevo, A. de Paiva, F. Lopez, A. Coutinho, M. Teixeira, E. Barbosa, E. Fonoff (São Paulo, Brazil)
Effects of different intensity exercises on motor function of PD rats as well as the regulation of DA

x. Liu, p. Chen, d. Qiao, m. wang (Beijing, China)
Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)
Effects of education level on motor and non-motor symptoms of Brazilian patients with Parkinson’s disease.

E. Lirani-Silva, R. Vitório, P.C. Santos, C. Teixeira-Arroyo, L. Simieli, N. Conceicao, P. Sousa, L. Gobbi (Rio Claro, Brazil)
Effects of non-invasive electrical and magnetic stimulation to improve motor and cognitive function in Parkinson’s disease: a meta-analytical review

A. Goodwill, J. Lum, A. Hendy, M. Muthalib, L. Johnson, N. Albein-Urios, W.-P. Teo (Burwood, Australia)
Effects of subthalamic and nigral stimulation on gait kinematics in Parkinson’s disease

M. Scholten, J. Klemt, C. Plewnia, B. Bloem, F. Bunjes, R. Krüger, A. Gharabaghi, D. Weiss (Tübingen, Germany)
Effects of thalamic deep brain stimulation on posture and balance in patients with essential tremor

K. Lizarraga, A. Farooqi, A. Rasul, J. Jagid, C. Luca (Miami, FL, USA)
Effects of the administration of levodopa on postural control under visual tasks

C. Bonnet, A. Delval, L. Defebvre (Lille, France)
Effects of TRH therapy on the prism adaptation task in patients with spinocerebellar degeneration.

T. Shimizu, R. Hanajima, R. Tsutsumi, K. Shimizu, N. Tominaga, Y. Ugawa, K. Nishiyama (Sagamihara, Japan)
Effects of zonisamide, an anti-parkinsonian drug, on cognition and BPSD in DLB patients: A post-hoc analysis of DLB Ph2 study

M. Murata, T. Odawara, O. Konishi, M. Nakamura, K. Kosaka (Tokyo, Japan)
Efficacy and Safety of a 2 mL Dilution of AbobotulinumtoxinA Compared With Placebo in Adult Patients With Cervical Dystonia

M. Lew, D. Snyder (Los Angeles, CA, USA)
Efficacy and safety of incobotulinumtoxinA (inco/A) for essential tremor using kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial

M. Jog, J. Lee, M. Althaus, A. Scheschonka, H. Dersch, E.T. Study Team, D. Simpson (London, ON, Canada)
Efficacy and Safety of Therapeutic Interventions to Treat Motor Symptoms in Late Stage Parkinson’s Disease: A Systematic Review

M. Coelho, K. Destri, M. Fabbri, A. Schrag, J. Ferreira, b.C. Consortium (Lisbon, Portugal)
Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study

F. Dematteis, M. Zibetti, E. Montanaro, L. Rizzi, M. Lanotte, L. Lopiano, M. Rizzone (Torino, Italy)
Efficacy of IncobotulinumtoxinA for the Treatment Of Shoulder Spasticity

D. Simpson, J. Wissel, D. Bensmail, A. Scheschonka, B. Flatau-Baqué, O. Simon (New York, NY, USA)
Efficacy of IncobotulinumtoxinA in Treatment of Lower Limb Spasticity in Adults

D. Simpson, J. Wissel, D. Bensmail, A. Scheschonka, B. Flatau-Baqué, O. Simon (New York, NY, USA)
Efficacy of miglustat in Korean patients with Niemann-Pick disease type C

J.W. Kim, S.-Y. Lee, R. Kim (Busan, Republic of Korea)
Efficacy of rotigotine as measured by individual Unified Parkinson’s Disease Rating Scale II and III items: a post-hoc analysis

M. Asgharnejad, H. Pesch, E. Dohin (Raleigh, NC, USA)
Efficacy of Smartphone-enabled Active Tests in Automated PD Severity Assessment

A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)
Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: results from the Phase 3 study dose-titration phase

R. Hauser, S. Isaacson, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro, H. Fernandez (Tampa, FL, USA)
Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)
Efficacy, Safety, and Tolerability of Pridopidine in Huntington Disease (HD): Results From the Phase II Dose-Ranging Study, Pride-HD

R. Reilmann, A. McGarry, G. Landwehrmeyer, K. Kieburtz, I. Grachev, E. Eyal, J. Savola, B. Borowsky, S. Papapetropoulos, M. Hayden (Münster, Germany)
Efficient control of dopamine neuron physiology for rescuing disease phenotypes

T. Rumbell, J. Kozloski (Yorktown Heights, NY, USA)
Eight contact LFP recordings in the Subthalamic region localize beta source to the dorsal STN

I. Tamir, C. de Hemptinne, J. Ostrem, P. Starr (San Francisco, CA, USA)
Eight contacts with multiple-source current steering in pallidal deep brain stimulation for Parkinson’s disease: a non-randomized, single center, open-lavel study

K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, K. Hamada, F. Tanaka (Yokohama, Japan)
Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)
Electronic stethoscope in the diagnosis of orthostatic tremor

J. Tashiro, H. Otsuka, M. Hirotani, S. Hamada, H. Soma, M. Nonaka, S. Honma, K. Hamada, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)
Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease

N. Dissanayaka, T. Au, A. Angwin, J. O'Sullivan, G. Byrne, P. Silburn, R. Marsh, G. Mellick, D. Copland (Brisbane, Australia)
Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson’s disease

P. Lingor, A. Leha, B. Michalke, M. Börger, M. Bähr, I. Zerr, F. Maass (Göttingen, Germany)
Elevated GM3 Plasma Concentration in Idiopathic Parkinson’s Disease: a Lipidomics Analysis

R. Alcalay, R. Chan, C. Liong, A. Perotte, B. Zhou, E. Shorr, K. Marder, U. Kang, C. Waters, O. Levy, Y. Xu, H. Shim, I. Pe'er, G. Di Paolo (New York, NY, USA)
Emergence of Non-motor Fluctuations with Reference to Motor Fluctuations in Parkinson’s Disease

A. Kim, Y. Kim, A. Kim, C.W. Shin, B. Jeon, H. Kim (Seoul, Republic of Korea)
EMG-US guided incobotulinum toxinA treatment of a cohort of musicians affected by upper limb focal dystonia

A. Castagna, M. Ramella, G. Giacobbi, P. Cecconi, R. Converti (Milano, Italy)
Emotion regulation and neuropsychological status in psychogenic subtypes.

B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)
End of Life Care in Parkinson’s Disease

S. Mole, S. Jackson (Exeter, United Kingdom)
Epidemiological profile and challenges of a reference public center for the treatment of neurological conditions using botulinum toxin type A: experience of a North-eastern center in Brazil.

R. Prado, W. Cunha, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)
Epidemiological profile of parkinsonism in a tertiary neurological clinic in the northeast of Brazil.

R. Prado, P. Macêdo, A. Santiago, R. Sá, J. Santos, M. Machado (Aracaju, Brazil)
Epilepsy and Cranial nerve affection in a Patient with Wilson’s disease and Intracranial developmental venous anomaly; A Case Report

W. Ezzat, A. Mohamed (cairo, Egypt)
Epitope mapping of CSF auto-antibodies to alpha-synuclein

R. Akhtar, J. Licata, K. Luk, D. Covell, J. Trojanowski, V. Lee (Philadelphia, PA, USA)
Essential Tremor and Depression

S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill (Phoenix, AZ, USA)
Estimation of Tardive Dyskinesia Incidence and Prevalence in the United States

A. Dhir, T. Schilling, V. Abler, R. Potluri, B. Carroll (New York, NY, USA)
Evaluating Non-Motor Fluctuations in Parkinson’s Disease Using a Visual Analogue Scale

E. Brown, K. Dodenhoff, J. Ostrem, C. Racine (San Francisco, CA, USA)
Evaluating the Clinical Efficacy of the Personal KinetiGraph Movement Recording System

A. Fowler, K. Lyons, V. Sharma, R. Pahwa (Kansas City, KS, USA)
Evaluating the Experience of Diagnosis in Parkinson’s Disease

A. Robinson, E. Pearson, F. Murphy, J. Davis, C. Carroll (Plymouth, United Kingdom)
Evaluating Use of the DBS Patient Programmer

D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)
Evaluating wearable sensors for objective measurement of motor features in Parkinson disease and Huntington disease – a pilot study

J. Adams, M. Xiong, K. Dinesh, C. Tarolli, S. Sharma, N. Sheth, A.J. Aranyosi, W. Zhu, S. Goldenthal, K. Biglan, R. Dorsey, G. Sharma (Rochester, NY, USA)
Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy

P. Dowell, B. Patel, L. Ledbetter, K. Lyons, R. Pahwa (Kansas City, KS, USA)
Evaluation of Brainstem Auditory Evoked Response and Nerve Conduction in Parkinson’s Disease

D. AGRAWAL, N. AHMED, A. CHUGHTAI (ALIGARH-202002, India)
Evaluation of CSF cytokine profiles in people with Parkinson disease and age-matched controls.

G. Crotty, D. Vaughan, G. Moloney, G. O'Keeffe, S. O'Sullivan, A. Sullivan (Cork, Ireland)
Evaluation of mitochondrial dysfunction in fibroblasts and iPSC-derived dopaminergic neurons of patients affected by Multiple System Atrophy

G. Monzio Compagnoni, E. Frattini, F. Fortunato, D. Ronchi, A. Bordoni, M. Garbellini, S. Salani, M. Guida, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milano, Italy)
Evaluation of Patient-Reported Outcomes in Tardive Dyskinesia Patients With Underlying Psychotic and Mood Disorders in the ARM-TD and AIM-TD Trials

H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, K. Anderson (Cleveland, OH, USA)
Evaluation of rotigotine transdermal patch in combination with low or high dose levodopa in patients with Parkinson’s disease: post-hoc analysis

E. Dohin, F. Woltering, M. Asgharnejad (Brussels, Belgium)
Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker

S. Dey, N. Rai, A. Singh, S. Shekhar, A. Dey (New Delhi, India)
Evaluation of spike sorting algorithms applied to artificial spikes and to spikes recorded from the Subthalamic Nucleus of PD patients

J. Sukiban, N. Voges, I. Weber, T. Dembek, M. Denker, M. Barbe, S. Grün, L. Timmermann (Cologne, Germany)
Evaluation of SV2A expression with [18F]MNI-944 PET imaging in healthy controls (HC) and Parkinson disease (PD)

D. Russell, D. Alagille, V. Carroll, M. Thompson, J. Madonia, O. Barret, C. Constantinescu, J. Seibyl, K. Marek, G. Tamagnan (New Haven, CT, USA)
Evaluation of Swallowing Function in Parkinson’s Disease Patients with and without Dysphagia Complaints

E. Umay, E. Ozturk, I. Gundogdu, O. Delibas, A. Cakci, B. Gonenli, Y. Eren (Ankara, Turkey)
Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon

T. DANAILA, C. LAURENCIN, P. ROCHE, S. THOBOIS, M. CHEMINON, J. LUAUTE (BRON, France)
Event-related potentials and mild cognitive impairment in Parkinson’s disease.

J. Pagonabarraga, J. Marin-Lahoz, A. Horta, M. Cornella, H. Bejr-Kasem, S. Martinez-Horta, J. Pérez-Pérez, M.Á. Boti, J. Kulisevsky (Barcelona, Spain)
Evidence of putaminal petechial hemorrhage as the cause of hyperglycemic chorea

J.-J. Lin (Nantou, Taiwan)
Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)
Evolution in Dopamine Transporter (DaT) Scan Utilization Patterns and its Effect on Treatment Decisions: Results of the Next 200 Scans

X.X. Yu (Cleveland, OH, USA)
Evolution of Globus Pallidus Internus (GPi) Deep Brain Stimulation Targeting Over 15 Years

V. Holanda, L. Almeida, M. Okun, A. Patterson, W. Deeb, A. Shukla, K. Foote (Gainesville, FL, USA)
Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset

A. Nathan, S. Park, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)
Examining the brain reserve hypothesis in Parkinson’s disease

P.C. Lee, F. Artaud, F. Cormier, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, F. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, V. Mesnage, A. Brice, M. Vidailhet, J.-C. Corvol, A. Elbaz (Taipei, Taiwan)
Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication

J. Youn, J.W. Cho, J.-I. Lee (Seoul, Republic of Korea)
Excessive daytime sleepiness in Parkinson’s disease: risk factors and clinical associations

O. Babkina, O. Levin, M. Poluektov (Moscow, Russian Federation)
Exercise alters response of reward anticipation in the ventral striatum of subjects with Parkinson’s disease

M. Sacheli, D. Murray, N. Vafai, E. Shahinfard, M. Cherkasova, K. Dinelle, N. Neilson, J. McKenzie, S. Appel-Cresswell, M. McKeown, V. Sossi, A. Stoessl (Vancouver, BC, Canada)
Exercise preferences of people with Parkinson’s disease: preliminary findings of a discrete choice experiment

C. Canning, C. Canning, S. Paul, J. Bampton, C. Sherrington, K. Howard (Lidcombe, Sydney, Australia)
Exercise Trends Reported in Parkinson’s Patients

P. Raje, C. Branson, M.P. de Leon, M. Saint-Hilaire, A. Hohler, S. Ning (Boston, MA, USA)
Exergaming in Patients with Parkinson’s Disease

C. Gemin, L. da Silva, M. Ribas Corrêa, H. Ghizone Teive, S. Valderramas (Curitiba, Brazil)
Exome sequencing in patients with impulse control disorders in Parkinson’s disease: a pilot study

S. Prud'hon, F. Danjou, S. Bekadar, Y. Marie, A. Rastetter, J. Guégan, F. Cormier-Dequaire, S. Lesage, A. Brice, J.-c. Corvol (Paris, France)
Expanding the spectrum of Faciobrachial Dystonic Seizures

G. Riboldi, L. Borellini, G. Franco, M. Carrabba, P. Bernasconi, F. Andreetta, S. Corti, G. Comi, A. Di Fonzo (New York, NY, USA)
Expectations and Perceived Outcomes Following DBS for PD: A Case Series

D. Coughlin, M. Hernandez-Con, M. Pavon, M. Spindler, L. Chahine (Philadelphia, PA, USA)
Experience and outcomes of the first Movement Disorders Clinic in Honduras.

J. Ortiz, A. Medina, F. Naranjo (Tegucigalpa, Honduras)
Experience Of Pallidal Deep Brain Stimulation (DBS) In Dystonia At A Tertiary Care Centre In India.

D. Srinivas, P. Pal, R. Yadav (Bangalore, India)
Explicit movement control in functional movement disorders is characterized by reduced lateralized beta desynchronisation

T. Teodoro, A. Meppelink, S. Little, A. Macerollo, R. Grant, M. Edwards (London, United Kingdom)
Exploiting sequence data of genes involved in synthesis of plant derived enzyme inhibitors of Acetylcholinesterase that involve in antineurodegenerative acitivity.

N. No surname, M. Abdin (New Delhi, India)
Exploratory Clinical study of role of cerebral dopamine neurotrophic factor (CDNF) mediating endoplasmic reticulum stress (ERS) in Parkinson Disease

K. Terpstra, R. Mishra, S. Chiu (Hamilton, ON, Canada)
Exploring the neurophysiology of cervical dystonia using TMS-EEG

S. Singh, H. Cho, N. Thirugnanasambandam, H. Shitara, O. Panyakaew, M. Hallett (Bethesda, MD, USA)
Exposure to bifenthrin contributes to Parkinson’s disease in mouse model

C. Han, S. Liu, J. Huang, L. Liu, K. Ma, X. Guo, S. Guo, L. Wang, Y. Shen, Y. Xia, F. Wan, N. Xiong, T. Wang (Wuhan, China)
Expression of late cell cycle markers in Parkinson Disease and Lewy Body Dementia

I. Martinez-Valbuena, R. Valenti-Azcarate, M.M. Carmona-Abellan, I. Marcilla-Garcia, I. Gaston-Zubimendi, G. Marti-Andres, M.-T. Tuñon-Alvarez, M.-R. Luquin-Piudo (Pamplona, Spain)
Expression of OX40 and OX40 serum level in patients with Parkinson’s disease

F. Alsahebfosoul, A. SeyedJoodaki, N. Eskandari, V. Shaygannejad, M. Salehi, M. Kazemi, M.T. Kardi, O. Mirmossayeb (Isfahan, Islamic Republic of Iran)
Extended “Timed Up and Go”: A Clinical Indicator of Cognitive State in Parkinson’s Disease?

T. Evans, A. Jefferson, M. Byrnes, S. Walters, S. Ghosh, F. Mastaglia, B. Power, R. Anderton (Perth, Australia)
Extracellular alpha-synuclein internalizes into cells by hijacking endocytic trafficking of dopamine transporter

J. Kobayashi, T. Hasegawa, N. Sugeno, S. Yoshida, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)
Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study

M. Rizzone, F. Dematteis, A. Chiò, S. Cammarosano, C. Artusi, M. Pagani, F. Nobili, A. Cistaro, M. Balma, E. Montanaro, B. Iazzolino, A. Canosa, L. Lopiano, A. Calvo (Torino, Italy)
Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: is TNF alpha the link?

T. Drori, J. Chapman, M. Lidar, P. Langevitz, Y. Shoenfeld, O. Cohen (Ramat-Gan, Israel)
Extreme Premature Ejaculation in Parkinson’s disease

G. Yahalom, G. Bronner, S. Israeli-Korn, S. Hassin-Baer (Ramat-Gan, Israel)
Eye Movements in Huntington Disease Like 2

D. Anderson, R. Margolis, A. Krause (Johannesburg, South Africa)